A lot of really nervous investors around at the moment which is...

A lot of really nervous investors around at the moment which is understandable considering the state of the world and global markets. However lets not forget RAP is in a prime position to benefit from the increase in respiratory related awareness and the exponential growth in telehealth as a result of COVID-19. Even without a direct COVID-19 related product. Either be patient and let them deliver on commercialisation (acknowledging its a tough time for everyone) or move on and look for other opportunities or protect your cash.

The above article is a great insight into Tony and reaffirms one of my fundamental thoughts about the company. Tony worked at UniQuest and facilitated the commercialisation of many of the UQs research areas, he even acted as interim CEO for a number of startups and yet ResApp is the one he chose to risk his career to pursue. He understands that opportunity that this technology holds and is actively working to achieve it.

Not doubt we have had setbacks, and management have a responsibility to take ownership of them and learn, which I believe they have. Rap is now weeks away from integration into Coviu and sustained revenue and positioning themselves to deliver more deals across Europe and Australasia. The WA initiative led by Twiggy Forest is an example of the opportunities that are being pursued behind the scenes. People need to stop expecting daily updates and have confidence in their investment.